← Browse by Condition
Medical Condition
bipolar 1 disorder
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4, Phase 2
NCT04580134 Phase 4
Recruiting
CLOZAPINE Response in Biotype-1
Enrollment
524 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT07046494 Phase 2
Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Enrollment
224 pts
Location
United States
Sponsor
Rapport Therapeutics Inc.